» Articles » PMID: 22343631

Outer Membrane Protein A (OmpA) of Shigella Flexneri 2a Links Innate and Adaptive Immunity in a TLR2-dependent Manner and Involvement of IL-12 and Nitric Oxide

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Feb 21
PMID 22343631
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We determine that OmpA of Shigella flexneri 2a is recognized by TLR2 and consequently mediates the release of proinflammatory cytokines and activates NF-κB in HEK 293 cells transfected with TLR2. We also observe that in RAW macrophages TLR2 is essential to instigate the early immune response to OmpA via NF-κB activation and secretion of cytokines and NO. Consistent with these results, TLR2 knockdown using siRNA abolishes the initiation of immune responses. Processing and presentation of OmpA depend on TLR2; MHCII presentation of the processed antigen and expression of CD80 significantly attenuated in TLR2 knockdown macrophages. The optimum production of IFN-γ by the macrophages:CD4(+) T cells co-culture depends on both TLR2 activation and antigen presentation. So, TLR2 is clearly recognized as a decisive factor in initiating host innate immune response to OmpA for the development of CD4(+) T cell adaptive response. Furthermore, we demonstrate in vivo that intranasal immunization of mice with OmpA selectively enhances the release of IFN-γ and IL-2 by CD4(+) T cells. Importantly, OmpA increases the level of IFN-γ production in Ag-primed splenocytes. The addition of neutralizing anti-IL-12p70 mAb to cell cultures results in the decreased release of OmpA-enhanced IFN-γ by Ag-primed splenocytes. Moreover, coincubation with OmpA-pretreated macrophages enhances the production of IFN-γ by OmpA-primed CD4(+) T cells, representing that OmpA may enhance IFN-γ expression in CD4(+) T cells through the induction of IL-12 production in macrophages. These results demonstrate that S. flexneri 2a OmpA may play a critical role in the development of Th1 skewed adaptive immune response.

Citing Articles

Transformable nano-antibiotics for mechanotherapy and immune activation against drug-resistant Gram-negative bacteria.

Li R, Liu J, Wen C, Shi Y, Ling J, Cao Q Sci Adv. 2023; 9(34):eadg9601.

PMID: 37624881 PMC: 10456869. DOI: 10.1126/sciadv.adg9601.


Shigella Outer Membrane Vesicles as Promising Targets for Vaccination.

Qasim M, Wrage M, Nuse B, Mattner J Int J Mol Sci. 2022; 23(2).

PMID: 35055181 PMC: 8781765. DOI: 10.3390/ijms23020994.


Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.

Kumar S, Sunagar R, Gosselin E Front Immunol. 2019; 10:1144.

PMID: 31191528 PMC: 6549121. DOI: 10.3389/fimmu.2019.01144.


Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages.

Bae E, Seo S, Kim C, Jang M, Song M, Lee T J Innate Immun. 2019; 11(4):316-329.

PMID: 30844806 PMC: 6738265. DOI: 10.1159/000494098.


Outer Membrane Protein of Gut Commensal Microorganism Induces Autoantibody Production and Extra-Intestinal Gland Inflammation in Mice.

Yanagisawa N, Ueshiba H, Abe Y, Kato H, Higuchi T, Yagi J Int J Mol Sci. 2018; 19(10).

PMID: 30347705 PMC: 6214128. DOI: 10.3390/ijms19103241.


References
1.
Langlet C, Springael C, Johnson J, Thomas S, Flamand V, Leitges M . PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Eur J Immunol. 2009; 40(2):505-15. DOI: 10.1002/eji.200939391. View

2.
Sallusto F, Lenig D, Mackay C, Lanzavecchia A . Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998; 187(6):875-83. PMC: 2212187. DOI: 10.1084/jem.187.6.875. View

3.
Bogdan C, Rollinghoff M, Diefenbach A . Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol. 2000; 12(1):64-76. DOI: 10.1016/s0952-7915(99)00052-7. View

4.
Cobb B, Wang Q, Tzianabos A, Kasper D . Polysaccharide processing and presentation by the MHCII pathway. Cell. 2004; 117(5):677-87. PMC: 2917993. DOI: 10.1016/j.cell.2004.05.001. View

5.
Gordon S . Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1):23-35. DOI: 10.1038/nri978. View